Drug-induced male sexual dysfunction. An update

Drug Saf. 1993 Jun;8(6):414-26. doi: 10.2165/00002018-199308060-00003.

Abstract

Impotence, defined as the consistent inability to maintain an erect penis of sufficient rigidity for sexual intercourse, has been estimated to affect 10 million American men. An age dependence has been shown to exist, with 25% of men over age 65 affected. A large body of clinical experience and published reports in the literature link many commonly prescribed drugs with sexual dysfunction. Drugs can affect sexual function at a variety of points such as inhibition of ejaculation or sedation/depression leading to reduced libido. Antihypertensive drugs have been most commonly associated with impotence. There have been reports of sexual dysfunction with almost all classes of antipsychotics, but little clinical investigation has been performed. Other drugs associated with sexual dysfunction include digoxin, clofibrate, cimetidine and various hormonal agents and antineoplastics. An important first step in approaching all impotent patients is the taking of a detailed medical, surgical, sexual and drug/substance abuse history. The least invasive form of therapy should be employed. Recent studies have shown intracavernous injections of alprostadil (prostaglandin E1) to be safe and effective for long term use. Vacuum constriction devices may also be of help. Better and more durable prostheses are now available should other treatment be unsuccessful.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antihypertensive Agents / adverse effects
  • Antineoplastic Agents / adverse effects
  • Ejaculation / drug effects*
  • Erectile Dysfunction / chemically induced*
  • Erectile Dysfunction / therapy
  • Hormones / adverse effects
  • Humans
  • Male
  • Penile Erection / drug effects*
  • Psychotropic Drugs / adverse effects
  • Substance-Related Disorders

Substances

  • Antihypertensive Agents
  • Antineoplastic Agents
  • Hormones
  • Psychotropic Drugs